Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02079857 · ClinicalTrials.gov registry record · NA
Symptom Management for Irritable Bowel Syndrome
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 183
- Enrollment target
NCT02079857 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 183 participants.
The verdict
NCT02079857, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 183 participants
- Enrollment target
Study Summary
The objective of this study is to test the efficacy of a symptom management treatment strategy, Acupuncture/Moxibustion (Acu/Moxa), to improve the symptoms associated with Irritable Bowel Syndrome (IBS) in adults.
Interventions
- OTHER Standard protocol
- OTHER Individualized protocol
- OTHER Sham acupuncture/Placebo moxa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2012-11 |
| Est. Completion | 2019-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02079857
The ClinicalTrials.gov registry entry for NCT02079857 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 183 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Standard protocol is the first listed.
NCT02079857 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02079857 about?
NCT02079857 is a clinical study titled "Symptom Management for Irritable Bowel Syndrome". The objective of this study is to test the efficacy of a symptom management treatment strategy, Acupuncture/Moxibustion (Acu/Moxa), to improve the symptoms associated with Irritable Bowel Syndrome (IBS) in adults.
What is the current status of trial NCT02079857?
This trial is currently completed. It is a NA study. The enrollment target is 183 participants. The study started on 2012-11. Estimated completion is 2019-11-01.
What interventions are being tested in trial NCT02079857?
The interventions under investigation include: Standard protocol (OTHER), Individualized protocol (OTHER), Sham acupuncture/Placebo moxa (OTHER).
Who is sponsoring clinical trial NCT02079857?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.